Pfizer manager doing time for insider trading


Amit Dagar was charged in June 2023 with trading ahead of a November 2021 announcement that Paxlovid had reduced hospitalisations and deaths in high-risk patients by 89%, which sent the shares surging. — Reuters

NEW YORK: A former Pfizer Inc statistician was sentenced to nine months behind bars for making more than US$200,000 by trading on confidential information before a key announcement about the drugmaker’s Covid-19 treatment Paxlovid.

Amit Dagar, convicted of securities fraud and conspiracy after a one-week trial in January, was sentenced on Tuesday in a federal court in Manhattan by US District Judge Andrew L. Carter Jr.

He was charged in June 2023 with trading ahead of a November 2021 announcement that Paxlovid had reduced hospitalisations and deaths in high-risk patients by 89%, which sent the shares surging.

He had asked for a sentence of probation or home confinement.

The case is part of an effort by Manhattan US Attorney Damian Williams to crack down on corporate crime including insider trading.

The charges were announced the same day as the case against a trio of investors accused of trading on secret information about the merger plans of Digital World Acquisition Corp, the blank check company that took Donald Trump’s social media startup public. — Bloomberg

Follow us on our official WhatsApp channel for breaking news alerts and key updates!

Next In Business News

Gamuda on track to achieve order book aim
BLand sells 80% stake in loss-making JV firm
Gas processing to bolster Coastal’s revenue
AOB suspends Chengco, sanctions five auditors
UEM Edgenta in tie-up with 21 Estates
Healthcare sector revenue to continue rising in 2H
Country Heights disposes of its wholly owned subsidiary
Bank Negara unveils full QRI programme to boost corporate flexibility
FTSE4Good Bursa Malaysia Index adds 19 stocks
Thong Guan scraps plan to sell F&B ops

Others Also Read